Hextar Healthcare Bhd (XKLS:7803) Change In Receivables: RM16.2 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hextar Healthcare Bhd Change In Receivables?

Hextar Healthcare Bhd XKLS:7803 +9.09% Change In Receivables is RM16.2 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Hextar Healthcare Bhd's change in receivables for the quarter that ended in Mar. 2026 was RM8.5 Mil. It means Hextar Healthcare Bhd's Accounts Receivable declined by RM8.5 Mil from Dec. 2025 to Mar. 2026 .

Hextar Healthcare Bhd's change in receivables for the fiscal year that ended in Dec. 2025 was RM-0.8 Mil. It means Hextar Healthcare Bhd's Accounts Receivable increased by RM0.8 Mil from Dec. 2024 to Dec. 2025 .

Hextar Healthcare Bhd's Accounts Receivable for the quarter that ended in Mar. 2026 was RM14.3 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Hextar Healthcare Bhd's Days Sales Outstanding for the three months ended in Mar. 2026 was 42.03.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hextar Healthcare Bhd's liquidation value for the three months ended in Mar. 2026 was RM39.6 Mil.

Hextar Healthcare Bhd  (XKLS:7803) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hextar Healthcare Bhd's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=14.302/31.049*91
=42.03

2. In Ben Graham's calculation of liquidation value, Hextar Healthcare Bhd's accounts receivable are only considered to be worth 75% of book value:

Hextar Healthcare Bhd's liquidation value for the quarter that ended in Mar. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=31.867-24.881+0.75 * 14.302+0.5 * 43.709
=39.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hextar Healthcare Bhd Change In Receivables Related Terms

Hextar Healthcare Bhd Change In Receivables Historical Data

* Premium members only.

The historical data trend for Hextar Healthcare Bhd's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hextar Healthcare Bhd Change In Receivables Chart

Hextar Healthcare Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.23 7.78 -0.17 -4.45 -0.82

Hextar Healthcare Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.53 11.91 0.67 -4.87 8.53

Hextar Healthcare Bhd Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM16.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of RM16.2 Mil mean?
Hextar Healthcare Bhd (XKLS:7803) has a Change In Receivables of RM16.2 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Hextar Healthcare Bhd and its competitors.
Is Hextar Healthcare Bhd's Change In Receivables too high?
Hextar Healthcare Bhd's current Change In Receivables is RM16.2 Mil.
How does Hextar Healthcare Bhd's Change In Receivables compare to LIN and SHW?
Hextar Healthcare Bhd's Change In Receivables of RM16.2 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Chemicals company?
A good Change In Receivables depends on the Chemicals industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Hextar Healthcare Bhd and its competitors. Hextar Healthcare Bhd's current Change In Receivables is RM16.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hextar Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Hextar Healthcare Bhd (XKLS:7803) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.15, compared to a current price of RM0.06 — trading 60% below its estimated fair value. The current Change In Receivables is RM16.2 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Hextar Healthcare Bhd (XKLS:7803), the current Change In Receivables is RM16.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hextar Healthcare Bhd Business Description

Address Jalan Bercham, Lot 138201, Off 3/4 Mile, Kawasan Perindustrian Bercham, Ipoh, PRK, MYS, 31400
Hextar Healthcare Bhd is principally involved in investment holding. Through its subsidiaries, it manufactures and sells rubber gloves. The company offers a wide range of industrial and safety gloves, household rubber gloves, and disposable vinyl and nitrile gloves. The company operates in three segments: Gloves operation, Medical devices operation, and Investment holding. The company generates the majority of its revenue from the Gloves operation segment. It has operations in Europe, Asia, North and South America, and the Rest of the world.